SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CSX Corporation (CSX) trades at a trailing P/E of 27.4, forward P/E of 23.0. Trailing earnings yield is 3.64%, forward earnings yield 4.35%. PEG 1.14. Graham Number is $15.69.
Criteria proven by this page:
- VALUE (53/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 23.0 (down from trailing 27.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.14 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 3.64% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.35% as earnings recover.
- Analyst consensus target $39.00 (-8.3% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 54/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
53/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CSX
Valuation Multiples
P/E (TTM)27.4
Forward P/E23.0
PEG Ratio1.14
Forward PEG1.14
P/B Ratio6.02
P/S Ratio5.61
EV/EBITDA15.5
Per Share Data
EPS (TTM)$1.55
Forward EPS (Est.)$1.85
Book Value / Share$7.06
Revenue / Share$7.56
FCF / Share$2.11
Yields & Fair Value
Earnings Yield3.64%
Forward Earnings Yield4.35%
Dividend Yield1.25%
Graham Number$15.69
SharesGrow IV$14.02 (-67%)
Analyst Target$39.00 (-8.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
19.9 |
-1.90 |
2.91 |
3.07 |
2.00% |
| 2017 |
9.2 |
0.04 |
3.40 |
4.39 |
1.41% |
| 2018 |
16.1 |
-0.45 |
4.23 |
4.35 |
1.41% |
| 2019 |
17.3 |
2.23 |
4.86 |
4.83 |
1.32% |
| 2020 |
25.1 |
-1.84 |
5.31 |
6.57 |
1.15% |
| 2021 |
22.4 |
0.56 |
6.27 |
6.76 |
0.99% |
| 2022 |
16.1 |
1.00 |
5.24 |
4.46 |
1.29% |
| 2023 |
19.0 |
-3.08 |
5.81 |
4.75 |
1.27% |
| 2024 |
18.0 |
-8.24 |
5.00 |
4.30 |
1.49% |
| 2025 |
23.4 |
-1.67 |
5.13 |
4.79 |
1.44% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.60 |
$11.07B |
$1.71B |
15.5% |
| 2017 |
$2.00 |
$11.41B |
$5.47B |
48% |
| 2018 |
$1.28 |
$12.25B |
$3.31B |
27% |
| 2019 |
$1.39 |
$11.94B |
$3.33B |
27.9% |
| 2020 |
$1.20 |
$10.58B |
$2.77B |
26.1% |
| 2021 |
$1.68 |
$12.52B |
$3.78B |
30.2% |
| 2022 |
$1.95 |
$14.85B |
$4.17B |
28% |
| 2023 |
$1.85 |
$14.66B |
$3.72B |
25.3% |
| 2024 |
$1.79 |
$14.54B |
$3.47B |
23.9% |
| 2025 |
$1.54 |
$14.09B |
$2.89B |
20.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.85 |
$1.80 – $1.90 |
$14.49B |
$14.41B – $14.6B |
15 |
| 2027 |
$2.09 |
$1.96 – $2.16 |
$15.16B |
$14.99B – $15.45B |
15 |
| 2028 |
$2.28 |
$2.27 – $2.28 |
$15.75B |
$15.73B – $15.78B |
2 |
| 2029 |
$2.45 |
$2.41 – $2.50 |
$16.65B |
$16.45B – $16.92B |
1 |
| 2030 |
$2.69 |
$2.65 – $2.75 |
$17.47B |
$17.27B – $17.76B |
1 |
